New cheek wrinkle injections put to the test
Symptom relief
Not yet recruiting
This study tests the safety of two new injectable treatments, GP0122 and GP0124, for reducing lines and wrinkles in the cheek area. About 60 adults with moderate to severe cheek wrinkles will receive the treatment and be monitored for side effects and wrinkle improvement over 12 …
Phase: NA • Sponsor: Galderma R&D • Aim: Symptom relief
Last updated May 05, 2026 11:54 UTC